yoshiyuki yoshikawa

Dr. yoshiyuki yoshikawa

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
KTKoji Takimoto
Koji Takimoto
HTHideaki Takebayashi
Hideaki Takebayashi
YYyoshiyuki yoshikawa
yoshiyuki yoshikawa
HSHiromi Sasano
Hiromi Sasano
STSoma Tsujishita
Soma Tsujishita
KIKoji Ikeda
Koji Ikeda
The purpose of this study was to examine whether motoric cognitive risk syndrome (MCR) is associated with various indicators of independent living among community-dwelling older adults in Japan. The study design was a cross-sectional study, and the participants were 107 community-dwelling older adults (mean age 79 ± 7 years) who were living independently. The participants were administered the Questionnaire for Medical Checkup of Old-Old (QMCOO) as an indicator of health status and the Japan Science and Technology Agency Index of Competence (JST-IC) as an indicator of higher levels of functioning capacity, among others. In addition, we assessed physical frailty (J-CHS), sarcopenia (AWGS2019), and MCR (slow gait + subjective memory complaints), which are predictors of adverse events in the elderly. Multiple regression analysis with QMCOO as the response variable showed that MCR (p = 0.01, β: 0.25) and physical frailty (p < 0.01, β: 0.43) were significantly associated. In addition, analysis with JST-IC as the response variable showed that MCR (p = 0.03, β: −0.20), physical frailty (p = 0.01, β: −0.24) and age (p = 0.02, β: −0.21) were significantly associated. In conclusion, MCR was found to be similarly associated with QMCOO and JST-IC as physical frailty. It is expected that the MCR will be used as an initial screening tool to identify signs of risk in community-dwelling older people, as it is easy to diagnose.

31 October 2024 in Drug Discoveries & Therapeutics
Verified
Journal Article
Open access
PDF file
YYyoshiyuki yoshikawa
yoshiyuki yoshikawa
KSKiyo Sasaki
Kiyo Sasaki
KNKyoko Nagayoshi
Kyoko Nagayoshi
KNKenta Nagai
Kenta Nagai
YAYuki Aoyama
Yuki Aoyama
YKYoshinori Kitade
Yoshinori Kitade
In this study, we aimed to examine whether a wheelchair cushion placed directly atop a sling seat or deflection of the sling seat compensated by a pad along with the placement of a wheelchair cushion changed sitting pressure. Additionally, we examined whether these additions changed sitting comfort. For twenty healthy adults who consented to participate, measurements were taken for three types of cushions, each with and without padding, under six conditions. The cushion types tested included air (cushion A), urethane foam (cushion U), and three-dimensional thermoplastic elastomer (cushion T). A pressure distribution measurement equipment was used for the measurements. Following the measurement, the comfort of the wheelchair cushion was measured. The ischial area pressure of the cushion A pad was significantly lower than that without the pad. Cushions U and T were for ischial area pressure with a pad, resulting in a decreasing trend in ischial area pressure with a pad compared to that without a pad; however, the difference was insignificant. For all cushions, sitting comfort was significantly better in all groups with padding than in those without. In conclusion, ischial pressure can be dispersed by placing a pad on the seat surface of a wheelchair cushion, and pads were suggested to improve sitting comfort for all cushions.

4 September 2020 in Medicina
Verified
Journal Article
Open access
PDF file
KNKoji Nonaka
Koji Nonaka
JAJunichi Akiyama
Junichi Akiyama
YYyoshiyuki yoshikawa
yoshiyuki yoshikawa
SUSatsuki Une
Satsuki Une
KIKenichi Ito
Kenichi Ito
Background and Objective. 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) inhibits proinflammatory cytokines in microglial cells and monocytes. However, it is unclear whether 1,25(OH)2D3 inhibits proinflammatory cytokines in muscle cells. This study was conducted to investigate whether 1,25(OH)2D3 inhibits the production of proinflammatory cytokines, resulting in inhibition of the protein expression of E3 ubiquitin ligases and muscle protein loss. Materials and Methods. C2C12 myoblasts were proliferated in Dulbecco’s modified Eagle medium (DMEM) containing 10% fetal bovine serum, and myoblasts were differentiated into myotubes in DMEM containing 2% horse serum. Myotubes were treated with 1,25(OH)2D3 for 24 h, followed by lipopolysaccharide (LPS) stimulation for 48 h. Results. Interleukin (IL)-6 protein concentrations were higher in the culture supernatant following LPS stimulation compared to that without LPS stimulation (p < 0.001). However, the IL-6 concentration was significantly lower in C2C12 myotubes following 1,25(OH)2D3 treatment than in C2C12 myotubes without 1,25(OH)2D3 treatment (p < 0.001). The myosin heavy chain (MHC), muscle atrophy F-box, and muscle ring-finger protein-1 protein levels did not significantly differ (P = 0.324, 0.552, and 0.352, respectively). We could not compare tumor necrosis factor α (TNFα) protein levels because they were below the limit of detection of our assay in many supernatant samples, including in LPS-stimulated samples. Conclusions. 1,25(OH)2D3 inhibited increases in IL-6 protein concentrations in muscle cells stimulated by LPS, suggesting that 1,25(OH)2D3 inhibits inflammation in muscle cells. The findings suggest that 1,25(OH)2D3 can prevent or improve sarcopenia, which is associated with IL-6. The TNFα protein content could not be measured, and MHC was not decreased despite LPS stimulation of C2C12 myotubes. Further studies are needed to examine the effects of higher doses of LPS stimulation on muscle cells and use more sensitive methods for measuring TNFα protein to investigate the preventive effects of 1,25(OH)2D3 on increased TNFα and muscle proteolysis.

1 January 2022 in Sage Open Medicine
Verified
Journal Article
Open access
YYyoshiyuki yoshikawa
yoshiyuki yoshikawa
NMNoriaki Maeshige
Noriaki Maeshige
MUMikiko Uemura
Mikiko Uemura
MTMasayuki Tanaka
Masayuki Tanaka
NKNobuhide Kawabe
Nobuhide Kawabe
HTHiroto Terashi
Hiroto Terashi
Objectives: Tuning fork vibration sensation testing is widely used as a diagnostic test to detect diabetic neuropathy. However, evidence-based literature indicates that reliability between examiners is low. Attaching isosceles triangle diagrams on tuning forks lowers the discrepancy between examiners. This study aimed to analyze the relationship between vibration sensation measurement using an improved tuning fork and the presence of callus and wound development in patients with diabetic peripheral neuropathy. Methods: Participants included 56 general older adults and 52 patients with diabetic peripheral neuropathy. The methods included confirmation of the presence or absence of callus, range of motion of the ankle and the first metatarsophalangeal joint, vibratory sensitivity of the medial malleolus and the dorsal aspect of the first distal phalanx using an improved tuning fork, and touch-pressure sensitivity of the plantar aspect of the hallux. Patients with diabetic peripheral neuropathy were followed up for 3 years to check for the presence or absence of wounds. Results: When compared with the general older adults, the patients with diabetic peripheral neuropathy had significantly lower touch-pressure sensitivity ( p < 0.01), vibratory sensitivity at the distal phalanx ( p < 0.01) and medial malleolus ( p < 0.01), ankle dorsiflexion range of motion ( p < 0.01), and metatarsophalangeal joint extension range of motion ( p < 0.01). The area under the receiver operating characteristic curve with callus formation was 0.93 for the medial malleolus and 0.96 for the distal phalanx, indicating that the accuracy of the distal phalanx was higher ( p < 0.01) than the medial malleolus. According to the Cox proportional hazard analysis, the vibratory sensitivity of the distal phalanx was a significant risk factor for ulcer development ( p < 0.05). Conclusion: These findings suggest that the vibration sensation test, which we improved via the technique described in this study, is useful for predicting the occurrence of callus and ulcer.

25 August 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
YYyoshiyuki yoshikawa
yoshiyuki yoshikawa
NMNoriaki Maeshige
Noriaki Maeshige
AYAtomu Yamaguchi
Atomu Yamaguchi
MUMikiko Uemura
Mikiko Uemura
THTerutaka Hiramatsu
Terutaka Hiramatsu
HTHiroto Terashi
Hiroto Terashi
This secondary analysis study aimed to detect individual variables that influence the efficacy of monophasic pulsed microcurrent on pressure injury healing. Eleven patients with pressure injuries showing delayed healing underwent a microcurrent stimulation period and a placebo period. We analyzed the correlation between the individual variables and the following three outcomes using monophasic pulsed microcurrent: the wound reduction rate in the electrical stimulation period, the reduction rate in the placebo period, and the difference between these two reduction rates. Furthermore, the patients were divided into two groups, one with a wound reduction rate of more than 10% and the other with less than 10%, and the relationship between each variable was compared. As a result, the wound reduction rate in the electrical stimulation period and the difference in the reduction rate between the two periods showed significant positive correlations with patients’ body mass index. In addition, a significant difference was observed in the body mass index between subjects with a reduction rate of 10% or higher and those with a reduction rate of less than 10%. This study found a correlation between the effect of monophasic pulsed microcurrent for pressure injury healing and the level of patients’ body mass index.

3 December 2025 in Clinical Physiology and Functional Imaging
Verified
Journal Article
Closed access
RNRio Nakamine
Rio Nakamine
RMRyoga Matsumoto
Ryoga Matsumoto
MMMisaki Matsumoto
Misaki Matsumoto
YYyoshiyuki yoshikawa
yoshiyuki yoshikawa
NMNoriaki Maeshige
Noriaki Maeshige